Enhabit (EHAB) Competitors $8.22 +0.26 (+3.27%) Closing price 10/8/2025 03:59 PM EasternExtended Trading$8.20 -0.02 (-0.24%) As of 10/8/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock EHAB vs. TDOC, OMDA, AHCO, PNTG, CDNA, FTRE, FLGT, INNV, CSTL, and PSNLShould you be buying Enhabit stock or one of its competitors? The main competitors of Enhabit include Teladoc Health (TDOC), Omada Health (OMDA), AdaptHealth (AHCO), The Pennant Group (PNTG), CareDx (CDNA), Fortrea (FTRE), Fulgent Genetics (FLGT), InnovAge (INNV), Castle Biosciences (CSTL), and Personalis (PSNL). These companies are all part of the "healthcare" industry. Enhabit vs. Its Competitors Teladoc Health Omada Health AdaptHealth The Pennant Group CareDx Fortrea Fulgent Genetics InnovAge Castle Biosciences Personalis Teladoc Health (NYSE:TDOC) and Enhabit (NYSE:EHAB) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, media sentiment, analyst recommendations, institutional ownership, dividends, valuation and profitability. Do insiders & institutionals hold more shares of TDOC or EHAB? 76.8% of Teladoc Health shares are held by institutional investors. 0.6% of Teladoc Health shares are held by company insiders. Comparatively, 3.4% of Enhabit shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Do analysts prefer TDOC or EHAB? Teladoc Health currently has a consensus price target of $9.86, suggesting a potential upside of 8.34%. Enhabit has a consensus price target of $8.67, suggesting a potential upside of 5.43%. Given Teladoc Health's stronger consensus rating and higher possible upside, research analysts plainly believe Teladoc Health is more favorable than Enhabit.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Teladoc Health 1 Sell rating(s) 11 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.28Enhabit 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is TDOC or EHAB more profitable? Teladoc Health has a net margin of -8.16% compared to Enhabit's net margin of -12.84%. Enhabit's return on equity of 2.72% beat Teladoc Health's return on equity.Company Net Margins Return on Equity Return on Assets Teladoc Health-8.16% -10.13% -4.43% Enhabit -12.84%2.72%1.25% Which has more risk & volatility, TDOC or EHAB? Teladoc Health has a beta of 1.9, indicating that its stock price is 90% more volatile than the S&P 500. Comparatively, Enhabit has a beta of 1.69, indicating that its stock price is 69% more volatile than the S&P 500. Does the media refer more to TDOC or EHAB? In the previous week, Teladoc Health had 14 more articles in the media than Enhabit. MarketBeat recorded 15 mentions for Teladoc Health and 1 mentions for Enhabit. Enhabit's average media sentiment score of 1.27 beat Teladoc Health's score of 0.91 indicating that Enhabit is being referred to more favorably in the news media. Company Overall Sentiment Teladoc Health Positive Enhabit Positive Which has higher earnings and valuation, TDOC or EHAB? Enhabit has lower revenue, but higher earnings than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than Enhabit, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTeladoc Health$2.57B0.63-$1.00B-$1.19-7.65Enhabit$1.03B0.40-$156.20M-$2.67-3.08 SummaryTeladoc Health beats Enhabit on 10 of the 16 factors compared between the two stocks. Get Enhabit News Delivered to You Automatically Sign up to receive the latest news and ratings for EHAB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EHAB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EHAB vs. The Competition Export to ExcelMetricEnhabitMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$403.49M$8.17B$6.09B$22.02BDividend YieldN/A2.83%5.69%3.58%P/E Ratio-3.0874.0085.5629.86Price / Sales0.4032.99535.6564.35Price / Cash1.9522.8037.9224.43Price / Book0.756.9713.034.64Net Income-$156.20M$247.60M$3.30B$1.01B7 Day Performance1.85%1.11%4.35%0.44%1 Month Performance4.24%0.75%9.50%3.13%1 Year Performance15.45%13.32%85.16%15.30% Enhabit Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EHABEnhabit2.346 of 5 stars$8.22+3.3%$8.67+5.4%+12.6%$403.49M$1.03B-3.0810,700News CoveragePositive NewsAnalyst ForecastTDOCTeladoc Health1.7578 of 5 stars$7.79-5.1%$9.80+25.8%+4.4%$1.37B$2.57B-6.515,500News CoverageAnalyst ForecastOptions VolumeOMDAOmada HealthN/A$22.16-0.7%$24.50+10.6%N/A$1.28B$209.83M0.00849News CoveragePositive NewsAnalyst ForecastAHCOAdaptHealth3.6321 of 5 stars$8.81+1.4%$13.40+52.2%-12.7%$1.19B$3.26B16.3110,500Analyst ForecastPNTGThe Pennant Group4.0529 of 5 stars$25.25+0.3%$34.40+36.3%-24.3%$873.16M$695.24M32.397,000CDNACareDx4.6298 of 5 stars$14.49-2.5%$25.50+75.9%-54.0%$774.34M$333.79M14.26740News CoverageAnalyst ForecastFTREFortrea3.0531 of 5 stars$8.39-0.1%$11.50+37.1%-45.7%$761.81M$2.70B-0.7415,500News CoverageAnalyst UpgradeGap UpFLGTFulgent Genetics3.1274 of 5 stars$22.39+0.4%$25.33+13.2%+11.2%$685.21M$303.22M-13.491,313Analyst ForecastINNVInnovAge0.5392 of 5 stars$4.99+1.8%$5.00+0.2%+7.4%$676.84M$853.70M-21.702,440Analyst ForecastCSTLCastle Biosciences2.5969 of 5 stars$22.46+0.4%$37.00+64.7%-21.4%$652.44M$332.07M-64.26540Analyst ForecastPSNLPersonalis3.0922 of 5 stars$6.29-1.0%$7.42+18.0%+66.6%$557.80M$84.61M-4.91400Analyst Forecast Related Companies and Tools Related Companies TDOC Competitors OMDA Competitors AHCO Competitors PNTG Competitors CDNA Competitors FTRE Competitors FLGT Competitors INNV Competitors CSTL Competitors PSNL Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:EHAB) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA Huge Shift Is Underway in AmericaWall Street legend issues chilling new warning: "I've never seen anything as dangerous as this" The man who...Stansberry Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enhabit, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enhabit With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
